CLINICAL_TRIALS
trial_result
· 2024-10-15
Clinical Trial Update: Pharmacokinetics, Safety and Efficacy of BIA 5-1058 in PAH (Zamicastat) [Phase 2]
Summary
Phase 2 trial assessing pharmacokinetics, safety, and efficacy of Zamicastat (BIA 5-1058) in pulmonary arterial hypertension; study completed with results poste…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2024-10-15